Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Molecular Imaging and Biology|March 18, 2017
In Vivo DCE-MRI for the Discrimination Between Glioblastoma and Radiation Necrosis in RatsJulie Bolcaen, Benedicte Descamps, Marjan Acou, et al.
Scientific Reports|October 18, 2019
Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancerKaat De Clercq, Feifan Xie, Olivier De Wever, et al.
Scientific Reports|September 21, 2022
Preclinical comparative study of [18F]AlF-PSMA-11 and [18F]PSMA-1007 in varying PSMA expressing tumorsSarah Piron, Jeroen Verhoeven, Jan Courtyn, et al.
Brain Connectivity|June 22, 2021
White Matter Integrity in a Rat Model of Epileptogenesis: Structural Connectomics and Fixel-Based AnalysisEmma Christiaen, Marie-Gabrielle Goossens, Benedicte Descamps, et al.
Cardiovascular Research|June 22, 2013
TLR2 activation causes no morbidity or cardiovascular failure, despite excessive systemic nitric oxide productionAnje Cauwels, Benjamin Vandendriessche, Jennyfer Bultinck, et al.
Scientific Reports|August 11, 2025
Perihematomal changes in glucose metabolism and cell counts in the rat collagenase model for intracerebral hemorrhageSilke Proesmans, Melissa Lajtos, Robrecht Raedt, et al.
Scientific Reports|November 20, 2021
Impact of the molar activity and PSMA expression level on [18F]AlF-PSMA-11 uptake in prostate cancerSarah Piron, Jeroen Verhoeven, Emma De Coster, et al.
Oncotarget|September 24, 2015
Radiation-induced lung damage promotes breast cancer lung-metastasis through CXCR4 signalingLynn Feys, Benedicte Descamps, Christian Vanhove, et al.
In Vivo (Athens, Greece)|December 29, 2015
Quantitative and Functional Requirements for Bioluminescent Cancer ModelsLynn Feys, Benedicte Descamps, Christian Vanhove, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|May 31, 2020
Radiosynthesis, in vitro and preliminary biological evaluation of [18 F]2-amino-4-((2-((3-fluorobenzyl)oxy)benzyl)(2-((3-(fluoromethyl)benzyl)oxy)benzyl)amino)butanoic acid, a novel alanine serine cysteine transporter 2 inhibitor-based positron emission tomography tracerTristan Baguet, Jakob Bouton, Jonas Janssens, et al.
Pageof 8